Formulating diets with high AME, especially in the grower and finisher phases, hinders the inclusion of alternative ingredients that are usually cheaper and have lower AME. Moreover, as the chicken grows the feed intake capacity is greater and may be able to maintain BW over a wide range of AME. The objective of this study was to evaluate the performance of chickens fed diets with progressive AME reductions, at constant or increased standardized ileal digestible (SID) lysine:AME ratio (Lys:AME). Treatment 1 (control) was formulated following the SID lysine and AME recommendations for a 4-phase feeding program. Treatment 5 was formulated with -4, -8, and -12% AME in the grower-1, grower-2, and finisher phases, respectively, and with the same Lys:AME compared with the control. Treatment 9 had the same AME as treatment 5 but higher SID lysine, increasing the Lys:AME by 1.5, 3.5, and 5.0% compared with treatment 5. In the grower-1, grower-2, and finisher phases, the final 9 dietary treatments were prepared by mixing the control diet with either treatment 5 or 9 at different proportions (75:25, 50:50, or 25:75). All birds were fed the same starter control diet. Treatments were replicated in 10 pens with 31 male chickens each, and the growth performance of birds was monitored for 42 d. Final BW linearly decreased (P < 0.05) when lowering dietary AME, but it followed a positive quadratic response with higher Lys:AME (P < 0.05). Feed intake increased (P < 0.05) with low AME, independently of the Lys:AME; but the linear regression in the feed conversion ratio (FCR) had a lower slope when the Lys:AME increased. At the end of the study, there were no differences in carcass or breast meat yield (P > 0.10). Progressively reducing AME in the last feeding phases may be a viable nutritional strategy to increase the inclusion of alternative ingredients and potentially reduce feeding costs, despite increments in feed intake and FCR. Adjusting the Lys:AME in low AME diets may help maintain the final BW of birds., Competing Interests: DISCLOSURES WDM, SS, and AIG currently work at Trouw Nutrition. JMR worked at Trouw Nutrition and FSQ was an intern during the execution of this trial., (Copyright © 2022 The Authors. Published by Elsevier Inc. All rights reserved.)